Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases

Infection by SARS-CoV-2 virus often induces the dysregulation of immune responses, tissue damage, and blood clotting. Engineered biomaterials from the nano- to the macroscale can provide targeted drug delivery, controlled drug release, local immunomodulation, enhanced immunity, and other desirable f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarubova, Jana, Zhang, Xuexiang, Hoffman, Tyler, Hasani-Sadrabadi, Mohammad Mahdi, Li, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942141/
https://www.ncbi.nlm.nih.gov/pubmed/33723531
http://dx.doi.org/10.1016/j.matt.2021.02.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942141/
https://www.ncbi.nlm.nih.gov/pubmed/33723531
http://dx.doi.org/10.1016/j.matt.2021.02.025

Ejemplares similares